Pharmafile Logo
Pharmafocus logo
Advanced Search
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

It’s Friday, and we’ve brought together our weekly digest of the articles which proved most popular with our readers. Mylan …

News
martin_shkreli_2016

‘He was born this way’, Shkreli case becomes circus

June 29, 2017
Medical Communications Martin Shkreli, Shkreli, Turing Pharmaceutical, turing

Martin Shkreli’s Attorney, Benjamin Brafman, defended his client in a bizarre reference to a pop singer, “As Lady Gaga would …

News
shutterstock_273326141

American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

June 29, 2017
Medical Communications, Research and Development American Cancer Society, Cancer, Melanoma Research Alliance, immunotherapy

The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact …

News
ingram_headshot

Sarepta appoints ex-Allergan President as new CEO

June 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sarepta Therapeutics

Sarepta Therapeutics has announced the appointment of ex-Allergan President Doug Ingram as the company’s new CEO – it’s third in …

Appointment
pounds_stacked

Regulators get aggressive on matters excessive

June 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen

Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …

Feature
heather_bresch_2

Investors demand resignation of Mylan executives over pay packages

June 29, 2017
Sales and Marketing Heather Bresch, Mylan, epipen

As confidence in Mylan continues to fall and share prices plummet after last year’s EpiPen pricing scandal and subsequent PR …

News
novartis_headquarters

Novartis gains first-line approval for Zykadia in lung cancer

June 29, 2017
Research and Development EMA, European Commission, NSCLC, Novartis

The European Commission has followed the EMA’s CHMP positive opinion by approving Novartis’ Zykadia for first-line treatment of patients with …

News
shutterstock_212035546

Investigational antibody boosts chemotherapy’s cancer-killing potential

June 29, 2017
Research and Development CFH, Cancer, oncology, rituximab

A proof-of-concept study conducted at the Duke Cancer Institute (DCI) in North Carolina has shown that an investigational antibody has …

News
brainss

Enzyme able to untangle protein aggregates associated with Alzheimer’s

June 29, 2017
Research and Development Alzheimer's, Parkinson's

There are currently no effective treatments for neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease. This is presently a pressing …

News
tablets-1796506_960_720

Researchers in world-first study on antibiotic use for sepsis

June 28, 2017
Research and Development NHS, antibiotic, sepsis

The University of Warwick, alongside the University of Manchester, are launching a world-first study aimed at determining the length of …

News

Regenacy names new President and CEO

June 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Regenacy, appointment

Simon S Jones has been revealed as the new President and Chief Executive Officer of Regenacy Pharmaceuticals, a biopharma company …

Appointment
rosemarie_finley_photo

Myeloma UK’s new CEO begins her role

June 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myeloma UK

Myeloma UK, the only organisation in the UK dealing exclusively with myeloma, will have a new CEO in place from …

Appointment

FT Global Pharmaceutical and Biotechnology Conference

June 28, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

News
Press release

Lonza cleared to acquire Capsugel in $5.5 billion deal

June 28, 2017
Manufacturing and Production, Research and Development, Sales and Marketing Capsugel, Lonza, acquisition

Swiss pharmaceutical manufacturer Lonza has announced that it has been cleared to proceed with its $5.5 billion acquisition of New …

News

Gold rods used to ‘break cancer’s legs’

June 28, 2017
Research and Development Cancer, Georgia Tech, nanorods

A study emerging from Georgia Tech has found a new way of stopping metastasising cancer’s spread through the body. The …

News
hack

MSD struck in second global cyber attack

June 28, 2017
Medical Communications, Research and Development Cyber attack, MSD

Following the recent and heavily-publicised ransomware attack which hit the NHS in the UK and almost 100 other countries, the …

News
microneedle-patch4004

Revolutionary patch could offer alternative to flu injections

June 28, 2017
Research and Development flu, flu vaccine, patch delivery

A patch developed by a team at the Georgia Institute of Technology alongside Emory University has found that it is …

News
fdaoutsideweb

FDA weighs in to improve generic competition

June 27, 2017
Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate

Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …

News

Novo Nordisk’s diabetes drug recommended for expanded indication in Europe

June 27, 2017
Research and Development, Sales and Marketing CHMP, EMA, EU, Novo Nordisk, Victoza

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has given its recommendation to expand the indication of Novo …

News
sanofi_regeneron

New potential blockbuster RA treatment enters European market

June 27, 2017
Sales and Marketing AbbVie, Humria, Kevzara, Regeneron, Sanofi

The world’s biggest selling drug, AbbVie’s Humira with $16 billion in sales last year, has a new rival in the …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026